Dual targeting of ErbB1 and ErbB2 enhances response to chemotherapy in ErbB2 overexpressing breast cancer cell lines.

被引：0
|
作者：
O'Donovan, N.
Clynes, M.
Crown, J.
机构：
[1] Dublin City Univ, Dublin 9, Ireland
[2] St Vincents Univ Hosp, Dublin, Ireland
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [1] Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR Cell Signaling Transduction Pathways for Cancer Chemotherapy
    Patnaik, Sunil Kumar
    Swaroop, Akey Krishna
    Nagarjuna, Palathoti
    Nanjan, Moola Joghee
    Chandrasekar, Moola Joghee Nanjan
    CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
  • [2] Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer
    Reinmuth, N
    Brandt, B
    Kunze, WP
    Junker, K
    Thomas, M
    Achatzy, R
    Scheld, HH
    Semik, M
    EUROPEAN RESPIRATORY JOURNAL, 2000, 16 (05) : 991 - 996
  • [3] Acquired resistance to a dual erbB1 and erbB2 kinase inhibitors
    Bacus, Sarah S.
    Hill, Jason
    Spector, Neil
    CANCER RESEARCH, 2006, 66 (08)
  • [4] Dual ErbB1/ErbB2 tyrosine kinase inhibition - a potential adjunct to systemic chemotherapy in bladder cancer
    McHugh, LA
    Griffiths, TRL
    Kriajevska, M
    Mellon, JK
    BJU INTERNATIONAL, 2005, 95 : 64 - 65
  • [5] Evaluation of AZD8931, an Equipotent Inhibitor of erbB1, erbB2, and erbB3 Receptor Signaling, on Ligand Stimulated Breast Cancer Cell Lines with Differing Levels of erbB2 Expression
    Marshall, G.
    Klinowska, T. C. M.
    Mills, E. A.
    Ogilvie, D.
    Hickinson, D. M.
    Speake, G.
    CANCER RESEARCH, 2009, 69 (24) : 784S - 785S
  • [6] A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
    Y Meng
    L Zheng
    Y Yang
    H Wang
    J Dong
    C Wang
    Y Zhang
    X Yu
    L Wang
    T Xia
    D Zhang
    Y Guo
    B Li
    Oncogenesis, 2016, 5 : e211 - e211
  • [7] A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
    Meng, Y.
    Zheng, L.
    Yang, Y.
    Wang, H.
    Dong, J.
    Wang, C.
    Zhang, Y.
    Yu, X.
    Wang, L.
    Xia, T.
    Zhang, D.
    Guo, Y.
    Li, B.
    ONCOGENESIS, 2016, 5 : e211 - e211
  • [8] Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells
    Pero, SC
    Shukla, GS
    Armstrong, AL
    Peterson, D
    Fuller, SP
    Godin, K
    Kingsley-Richards, SL
    Weaver, DL
    Bond, J
    Krag, DN
    INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (06) : 951 - 960
  • [9] Investigation of ErbB1 and ErbB2 expression for therapeutic targeting in primary liver tumours
    Altimari, A
    Fiorentino, M
    Gabusi, E
    Gruppioni, E
    Corti, B
    D'Errico, A
    Grigioni, WF
    DIGESTIVE AND LIVER DISEASE, 2003, 35 (05) : 332 - 338
  • [10] Cerulenin suppresses ErbB2-overexpressing breast cancer by targeting ErbB2/PKM2 pathway
    Lv, Sinan
    Zhang, Yunwu
    Song, Jiawei
    Chen, Jingruo
    Huang, Bohan
    Luo, Yuhan
    Zhao, Yuhua
    MEDICAL ONCOLOGY, 2022, 40 (01)
12345